The ‘doctor is in’ at select Meijer supercenters
CHICAGO According to published reports Meijer has opened physician-staffed health clinics in two of its Chicago stores, and plans to add a third by the end of the month. The new clinics, which operate under the name Medical Marts, are currently in operation in Aurora and St. Charles, Ill., and a third is planned for Algonquin.
The typical Medical Mart is staffed by two full-time primary care physicians, two full-time medical assistants or nurses, and provides a full range of health care services. Because it is a physician-staffed model versus the nurse practitioner-staffed model that is most common in the rapidly burgeoning retail health clinic industry, Medical Marts can offer a deeper menu of services on site, including extensive lab testing.
Medical Marts, which first emerged on the retail clinic scene in May 2006, when it announced a partnership with Shopko, also currently operates seven other clinics in Shopko stores in the state of Utah, including stores in Salt Lake City, Bountiful, West Jordan, West Valley, Ogden (2) and Logan, Utah.
In addition, Medical Mart is expected to open clinics in two Kmart pharmacy stores in Rockford, Ill., by November.
CIGNA debuts online Rx pricing guide for patients
BLOOMFIELD, Conn. Big insurance and pharmacy benefits management company CIGNA HealthCare has launched an updated version of its online Prescription Drug Price Quote tool for its health and PBM plan members as a price-comparison guide.
The web-based guide is available on the My Plans—Pharmacy page at www.mycigna.com. It offers Cigna Pharmacy members real-time, plan-specific cost comparisons for generic, brand name and available therapeutic alternative medications at 57,000 U.S. pharmacies, according to the health plan giant.
“Rather than relying on national average or regional discount information on retail pharmacy prices, the tool displays side-by-side comparisons of exactly what members would pay for brand named medications, available generics and low cost therapeutic options…based on their benefit plan, as well as the total cost of each medication,” Cigna noted in a statement.
Rexahn receives patent for Zoraxel
ROCKVILLE, Md. Rexahn Pharmaceuticals has received a U.S. Patent for the treatment of sexual dysfunction with its leading drug candidate RX-10100 IR, also known as Zoraxel.
Zoraxel is a drug that enhances neurotransmitters in the brain, both of which play key roles in sexual motivation, erection, and release. This would be the first drug to effect all three phases of sexual activity.
Commenting on today’s news, Chang H. Ahn, Ph.D., Chairman and Chief Executive Officer of Rexahn Pharmaceuticals, noted, “This latest patent coverage for Zoraxel significantly strengthens our patent estate. When added to the four CNS-related U.S. patents and two anti-cancer patents already secured, this represents another key milestone for the Company as we move forward with the clinical development for this promising new drug.”
The company plans to initiate a Phase II trial for Zoraxel by the end of this year.